Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9365526 Process for the preparation of dasatinib and its intermediates

Patent 9365526 was granted and assigned to Sun Pharmaceutical on June, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Sun Pharmaceutical

Current Assignee

Sun Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9365526

Patent Inventor Names

Rajesh Kumar Thaper0

Jagdev Singh Jaryal0

Mohan Prasad0

Munish Kapoor0

Swargam Sathyanarayana0

Date of Patent

June 14, 2016

Patent Application Number

14758644

Date Filed

December 31, 2013

Patent Citations Received

‌

US Patent 12064428 Kinase inhibitor salts and compositions thereof

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

Patent Primary Examiner

‌

Golam M. M. Shameem

Patent abstract

The present invention relates to processes for the preparation of dasatinib and its intermediates.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9365526 Process for the preparation of dasatinib and its intermediates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API